First Time Loading...

Thermo Fisher Scientific Inc
NYSE:TMO

Watchlist Manager
Thermo Fisher Scientific Inc Logo
Thermo Fisher Scientific Inc
NYSE:TMO
Watchlist
Price: 571.73 USD -0.98% Market Closed
Updated: Apr 26, 2024
Section:
 

Wall Street
Price Targets

TMO Price Targets Summary
Thermo Fisher Scientific Inc

Wall Street analysts forecast TMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMO is 617.54 USD with a low forecast of 525.2 USD and a high forecast of 689.85 USD.

TMO Lowest Forecast
Wall Street Target
525.2 USD
8% Downside
TMO Average Forecast
Wall Street Target
617.54 USD
8% Upside
TMO Highest Forecast
Wall Street Target
689.85 USD
21% Upside
Lowest
Price Target
525.2 USD
8% Downside
Average
Price Target
617.54 USD
8% Upside
Highest
Price Target
689.85 USD
21% Upside

TMO Last Price Targets
Thermo Fisher Scientific Inc

The latest public price target was made on Apr 25, 2024 by Luke Sergott from Barclays , who expects TMO stock to rise by 8% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Luke Sergott
Barclays
615 USD
Upside 8%
1 day ago
Apr 25, 2024
Thermo Fisher price target raised to $615 from $590 at Barclays
TheFly
Justin Bowers
Deutsche Bank
610 USD
Upside 7%
1 day ago
Apr 25, 2024
Thermo Fisher Scientific (TMO) PT Raised to $610 at Deutsche Bank
StreetInsider
Catherine Schulte
Robert W. Baird
670 USD
Upside 17%
3 months ago
Dec 28, 2023
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
Benzinga
Andrew Cooper
Raymond James
530 USD
Downside 7%
6 months ago
Oct 26, 2023
These Analysts Lower Their Forecasts On Thermo Fisher After Q3 Results
Benzinga
Thermo Fisher
Credit Suisse
620 USD
Upside 8%
9 months ago
Jul 13, 2023
Credit Suisse Upgrades Thermo Fisher, Calls It Best-Of-Breed Asset
Benzinga
Unknown Analyst
Citigroup
700 USD
Upside 22%
1 year ago
Feb 2, 2023
Citigroup Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $700
Benzinga
Unknown Analyst
Barclays
660 USD
Upside 15%
1 year ago
Feb 2, 2023
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $660
Benzinga
Unknown Analyst
Leerink Partners
630 USD
Upside 10%
1 year ago
Feb 2, 2023
SVB Leerink Maintains Outperform on Thermo Fisher Scientific, Raises Price Target to $630
Benzinga
Unknown Analyst
Cowen & Co.
711 USD
Upside 24%
1 year ago
Feb 2, 2023
Cowen & Co. Maintains Outperform on Thermo Fisher Scientific, Raises Price Target to $711
Benzinga
Show More Price Targets
Show Less Price Targets
Luke Sergott
Barclays
Price Target 615 USD
Upside/Downside 8%
View Source
Justin Bowers
Deutsche Bank
Price Target 610 USD
Upside/Downside 7%
View Source
Catherine Schulte
Robert W. Baird
Price Target 670 USD
Upside/Downside 17%
View Source
Andrew Cooper
Raymond James
Price Target 530 USD
Upside/Downside 7%
View Source
Thermo Fisher
Credit Suisse
Price Target 620 USD
Upside/Downside 8%
View Source
Unknown Analyst
Citigroup
Price Target 700 USD
Upside/Downside 22%
View Source
Unknown Analyst
Barclays
Price Target 660 USD
Upside/Downside 15%
View Source
Unknown Analyst
Leerink Partners
Price Target 630 USD
Upside/Downside 10%
View Source
Unknown Analyst
Cowen & Co.
Price Target 711 USD
Upside/Downside 24%
View Source
Show More Price Targets
Show Less Price Targets
Thermo Fisher Scientific Inc Competitors:
Price Targets
GSS
Genetic Signatures Ltd
12% Upside
M
300463
Maccura Biotechnology Co Ltd
48% Upside
ABCL
Abcellera Biologics Inc
332% Upside
CRL
Charles River Laboratories International Inc
21% Upside
GSS
Genetic Signatures Ltd
12% Upside
M
300463
Maccura Biotechnology Co Ltd
48% Upside
ABCL
Abcellera Biologics Inc
332% Upside
CRL
Charles River Laboratories International Inc
21% Upside
688621
Beijing Sun-Novo Pharmaceutical Research Co Ltd
32% Upside
TECN
Tecan Group AG
21% Upside
BANB
Bachem Holding AG
10% Downside
PPGN
PolyPeptide Group AG
28% Downside

Revenue
Forecast

Revenue Estimate
Thermo Fisher Scientific Inc

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's revenue is 12%. The projected CAGR for the next 3 years is 5%.

12%
Past Growth
5%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Thermo Fisher Scientific Inc

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's operating income is 14%. The projected CAGR for the next 3 years is 17%.

14%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-30%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Thermo Fisher Scientific Inc

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's net income is 15%. The projected CAGR for the next 3 years is 20%.

15%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-28%
Average Miss
What are analyst estimates?

See Also

Summary
TMO intrinsic value, competitors valuation, and company profile.
DCF Valuation
TMO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TMO stock valuation using valuation multiples.
Wall Street Estimates
TMO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TMO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TMO's stock price target?
Price Target
617.54 USD

According to Wall Street analysts, the average 1-year price target for TMO is 617.54 USD with a low forecast of 525.2 USD and a high forecast of 689.85 USD.

What is Thermo Fisher Scientific Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's revenue is 12%. The projected CAGR for the next 3 years is 5%.

What is Thermo Fisher Scientific Inc's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's operating income is 14%. The projected CAGR for the next 3 years is 17%.

What is Thermo Fisher Scientific Inc's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's net income is 15%. The projected CAGR for the next 3 years is 20%.

ALPHA SPREAD
Join more than 131,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.